Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Positive opinion based on a clinical development program involving over 1,000 people with type 1 or type 2 diabetes
Paris, France - May 19, 2017 - Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medi... Biopharmaceuticals, Regulatory Sanofi, Insulin lispro, Biosimilar
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Humalog | Insulin | Pharmaceuticals